<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04442100</url>
  </required_header>
  <id_info>
    <org_study_id>Easy Change</org_study_id>
    <nct_id>NCT04442100</nct_id>
  </id_info>
  <brief_title>The Study of Biological Prosthetic Heart Valves With the &quot;Easy Change&quot; System</brief_title>
  <official_title>The Study of Biological Prosthetic Heart Valves With the &quot;Easy Change&quot; System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tomsk National Research Medical Center of the Russian Academy of Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tomsk National Research Medical Center of the Russian Academy of Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study of new biological heart valves with the &quot;easy change&quot; system, including an
      assessment of the basic hemodynamic characteristics of the prosthesis, complications
      associated with valve implantation, and general mortality
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 29, 2016</start_date>
  <completion_date type="Anticipated">December 31, 2026</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2026</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>death</measure>
    <time_frame>10 years after surgery</time_frame>
    <description>death from any cause</description>
  </primary_outcome>
  <primary_outcome>
    <measure>prosthetic complications</measure>
    <time_frame>10 years after surgery</time_frame>
    <description>thromboembolism, infectious endocarditis, hemorrhage, structural valve degeneration</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Heart Valve Diseases</condition>
  <arm_group>
    <arm_group_label>bioprosthesis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>prosthetics of heart valves with dentures &quot;MedEng-Bio&quot;</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>valve prosthetics</intervention_name>
    <description>prosthetics of heart valves with dentures &quot;MedEng-Bio&quot;</description>
    <arm_group_label>bioprosthesis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. aortic valve disease requiring surgical disease patients without symptoms with severe
             aortic stenosis - indexed area of the opening less than 0.5 cm2 / m2, average gradient
             more than 40 mm RT. Art;

             o patients who require coronary artery bypass grafting with moderate aortic stenosis -
             indexed area of the hole 0.5 - 1 cm2 / m2, the average gradient is more than 20 mm RT.
             Art., Regardless of symptoms;patients with symptoms of aortic stenosis, regardless of
             the severity of stenosis)

          2. mitral valve disease requiring surgical disease

        Exclusion Criteria:

          1. the need for prosthetics of two or more valves

          2. patients with a decrease in LVEF of less than 45%;

          3. the presence of a competing disease or concomitant pathology that significantly
             affects the prognosis of quality of life or the likelihood of death

          4. high pulmonary hypertension (SDJ above 60 mm Hg. Art.);

          5. the diameter of the ascending aorta is more than 45 mm;

          6. unwillingness of the patient to participate in the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Boris N. Kozlov, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tomsk National Research Medical Center of the Russian Academy of Sciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ekaterina A/ Kosovskikh</last_name>
    <phone>+79528912091</phone>
    <email>katekorovina93@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Konstantin A. Petlin, PhD</last_name>
    <phone>+79138259164</phone>
    <email>kpetlin@yandex.ru</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tomsk National Research Medical Center of the Russian Academy of Sciences</name>
      <address>
        <city>Tomsk</city>
        <state>Tomsk Region</state>
        <zip>634012</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ekaterina A Kosovskikh</last_name>
      <phone>+79528912091</phone>
      <email>katekorovina93@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Boris N Kozlov, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Konstentin A Petlin, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 18, 2020</study_first_submitted>
  <study_first_submitted_qc>June 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 22, 2020</study_first_posted>
  <last_update_submitted>June 19, 2020</last_update_submitted>
  <last_update_submitted_qc>June 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tomsk National Research Medical Center of the Russian Academy of Sciences</investigator_affiliation>
    <investigator_full_name>Ekaterina Kosovskikh</investigator_full_name>
    <investigator_title>Ekaterina Alekseevna Kosovskikh</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Valve Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

